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Key Points
• Symptomatic diverticular disease patients can be separated into low (LSDD) and high (HSDD) somatization
groups based on Patient Health Questionnaire-12 (PHQ-12 SS)
• During anticipation of pain greater deactivations occur in somatosensory, emotional, and descending noxious
inhibitory control pain regions in the asymptomatic (ADD) compared to the symptomatic diverticular disease
(SDD) and irritable bowel syndrome (IBS) groups
• There are fewer anticipatory differences between the ADD and LSDD and the IBS and HSDD groups, suggesting
that the LSDD and HSDD grouping identifies DD patients with predominantly peripheral vs central factors,
respectively.
Abstract
Background The relative importance of peripheral
nerve injury or central pain processing in painful
diverticular disease (DD) is unclear. Functional mag-
netic resonance imaging (fMRI) has demonstrated that
dysfunctional central pain processing predominates in
irritable bowel syndrome (IBS). This study aims to
identify anticipatory changes in symptomatic DD
(SDD) compared to asymptomatic DD (ADD) and
IBS patients.Methods Gastrointestinal symptoms and
somatization were evaluated via the Patient Health
Question-12 Somatic Symptom and the SDD group
divided into low (≤6 [LSDD]) and high (≥7 [HSDD])
somatization. Cued painful cutaneous thermal stim-
uli were delivered to the left hand and foot during
fMRI. Fixed effect group analysis of the ‘cued’ antic-
ipatory phase was performed. Key Results Within the
right posterior insula, greater deactivation was found
in the ADD compared to other groups. In emotion
processing centers, anterior and middle insula, greater
activation was identified in all patient compared to
the ADD group, and in LSDD compared to IBS and
HSDD groups. In comparison, amygdala deactivation
was greater in ADD than the IBS and HSDD groups,
and in LSDD vs HSDD groups. Descending nocicep-
tive control centers, such as the superior medial
frontal and orbitofrontal cortex, also showed greater
deactivation in the ADD and LSDD compared to the
HSDD and IBS groups. Conclusions & Inferences The
HSDD group have altered anticipatory responses to
thermal pain, similar to IBS group. The LSDD are
similar to ADD group. This suggests underlying
differences in pain pathophysiology, and the need for
individualized treatment strategies to target the cause
of their chronic pain.
Keywords anticipation, diverticular disease, func-
tional MRI, pain.
Abbreviations: ACC, anterior cingulate cortex; ADD,
asymptomatic diverticular disease; aINS, anterior
insula; AMYG, amygdala; CHEPS, Contact Heat-
Evoked Potential Stimulator; DNIC, descending nox-
ious inhibitory control; EPI, echo-planar imaging;
fMRI, functional magnetic resonance imaging; GLM,
general linear model; HAD, Hospital Anxiety and
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Depression Score; HSDD, high somatization score
symptomatic diverticular disease; IBS, irritable bowel
syndrome; INS, insula; lat, lateral; LSDD, low soma-
tization score symptomatic diverticular disease; MCC,
mid-cingulate cortex; mPFC, medial prefrontal cortex;
PCS, pain catastrophizing score; PFC, prefrontal cor-
tices; PHQ-12 SS, Patient Health Questionnaire-12
Somatic Symptom; PHQ-15, Patient Health Question-
naire-15; pINS, posterior insula; RFX, random effects;
SDD, symptomatic diverticular disease; SPMMRC, Sir
Peter Mansfield Magnetic Resonance Centre; THAL,
thalamus; VAS, visual analog score.
INTRODUCTION
Colonic diverticulosis (DD)1 is the most common
structural abnormality of the colon, yet our under-
standing of how it causes symptoms is rudimentary. It
is responsible for substantial morbidity and mortality,
with 254 179 hospital admissions, 1 493 865 outpa-
tient visits in 2002 in the USA,2 and 23 000 deaths per
year in Europe.3 Studies suggest its incidence and/or
complications4 are increasing5–8 with an associated
increase in cost.9
While the acute complications of DD are well
recognized, chronic painful symptomatic diverticular
disease (SDD), in the absence of acute diverticulitis, is
a poorly understood complication which causes much
distress. Risk factors for developing SDD include a
previous episode of inflammation, such as diverticuli-
tis, adverse psychological conditions,4 low levels of
physical activity,10 high BMI,11 and smoking.12 We and
others have previously shown that SDD is associated
with changes in colonic innervation, including
increases in tachykinins, substance P, acetylcholine,
nitric oxide, endocannabinoids, and galanin in the
submucosal plexus and circular muscle,13,14 and
increases in neuronal angulation and density.13 This
suggests an underlying peripheral nerve response to
inflammation, which by analogy with animal stud-
ies,15 would be expected to result in hypersensitivity to
colorectal distension.
Like SDD, there is a well-recognized subgroup of
IBS, postinfectious IBS (PI-IBS), where symptoms and
mucosal changes occur after an inflammatory episode,
such as gastroenteritis.16 However, psychological fac-
tors, such as neuroticism and depression increase the
risk of developing PI-IBS.17 Anxiety, depression, and
somatization, are also important to a lesser extent in
SDD, and other conditions. The Patient Health Ques-
tionnaire-12 Somatic Symptom scale (PHQ-12 SS) has
been used to assess somatization in SDD and IBS.18
The PHQ-12 SS is a modified version of the PHQ-15,
but with three questions concerning gastrointestinal
symptoms excluded. Using a PHQ-12 SS score of
greater than six, 67% of IBS and 55% of SDD patients
have values above the normal range.18
These findings suggest that in both groups there are
some individuals who have a predominantly postin-
flammatory disorder, possibly mediated by peripheral
nerve hypersensitivity, with few other symptoms (i.e.,
low somatization or PHQ-12 SS score), and others who
have a more central cerebral-based pain processing
disturbance as indicated by a high somatization or
PHQ-12 SS score.19
There have been no studies characterizing central
brain responses in DD, but we have previously found
that somatization is a risk factor for developing DD
symptoms, suggesting that alterations in pain process-
ing may be present.4 Alteration in somatization and
pain processing has been identified in patients with
IBS.20,21 Although there are some similarities between
DD and IBS, there are also key differences, such as
older age of onset, lesser female predominance, and the
lack of pain relief after defecation in SDD.4,22 We
hypothesize that the SDD group, like IBS, can be
separated into low (low somatization score SDD;
LSDD) and high (high somatization score SDD; HSDD)
somatizers based on the PHQ-12 SS score.
Prior studies have suggested that the anticipation of
pain may involve a network of brain areas. This
includes the posterior insula, and anterior cingulate
cortex (ACC) and anterior insula, key areas associated
with somatosensory and emotional pain processing
pathway and interoception.23,24 In addition, affective
brain regions of orbitofrontal cortex and amygdala, and
the mid-cingulate cortex (MCC) are of interest as these
are implicated in fear processing and nociception.25 So
also is the ventrolateral prefrontal cortex which is
involved in the cognitive modulation of pain26 and
diffuse noxious inhibitory control (DNIC)27 in bottom-
up modulation of the neural activity underlying pain
together with the anterior and MCC.
The aim of this study was to identify differences in
cerebral responses to the anticipation of pain in the
SDD group based on PHQ-12 SS somatization score,
and to determine if high somatization was associated
with an IBS-like response to anticipation of pain.
MATERIALS AND METHODS
Subjects
Study participants with IBS, ADD, and SDD were identified and
recruited from gastrointestinal medicine and surgery clinics and
© 2016 The Authors.
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databases of interested patients held at the Nottingham Digestive
Diseases Centre (NDDC) NIHR BRU. Confirmation of the partic-
ipants’ gastrointestinal diagnosis and the initial screening ques-
tions for inclusion and exclusion criteria (Table 1) were addressed
by structured telephone questionnaire, before the study day.
Detailed inclusion and exclusion criteria have been included in
Table 1 to provide clarity in comparison with other studies as
suggested in a recent review.35 Sinceour SDDpatientshada rangeof
bowel habits our IBS cohort was recruited solely on the basis of the
Rome III criteria of recurrent abdominal pain/discomfort regardless
of bowel habit. All study participants had structural imaging as part
of their hospital diagnosis, either with flexible sigmoidoscopy or
colonoscopy, CT, or barium enema. The study was approved by the
Nottingham Regional Ethics Committee (09/H0403/43).
Sample size estimation
Based on the literature and our previous work,36,37 we estimated
that to show a >30% difference in functional magnetic resonance
imaging (fMRI) response between groups, which is conventionally
considered to be the minimal clinically significant difference,
with a 80% power using alpha <0.05 would require n = 12
subjects. We aimed to recruit 20 subjects in each group to allow
for a possible 40% drop-out rate and/or poor compliance with
fMRI protocol.
Questionnaires
Participants completed validated questionnaires on gastrointesti-
nal habits,14 Hospital Anxiety and Depression scores (HAD),38
somatic symptoms (PHQ-12 SS)18,39 and pain catastrophizing
score (PCS)40 the day before the scan session. None of the
participants’ usual medications or food were withheld before the
visit except for ondansetron (IBS participants).30,41
Study protocol
A Medoc PATHWAY System (Medoc, Israel) was used to deliver
thermal stimulation using a MR-compatible CHEPS (Contact
Heat-Evoked Potential Stimulator) 27-mm-diameter thermode
probe (Fig. 1A and B). Although no formal handedness question-
naires were performed, participants were asked to identify their
dominant hand based on the types of activities they preferentially
used it. The thermode was placed on the dorsum of the left non-
dominant hand or foot and maintained in place using a Velcro
strap and tubi-grip bandage. Thermal sensitivity measures were
undertaken outside of the MR scanner. To identify the unpleasant
but tolerable temperature at which to perform the study (moder-
ate pain temperature [MPT]), participants were asked to rate a
series of temperature on visual analog score (VAS). This is a score
of 0 to 10, where 0 = ‘no pain’ and 10 = ‘most severe pain ever
Table 1 Study Inclusion and Exclusion criteria
Inclusion criteria
Participants must
have either
Symptomatic diverticular disease with short-lived recurrent abdominal pain on 3 or more days a month and at least
one or more colonic diverticulum identified on endoscopy, barium enema, or CT scan
Asymptomatic diverticular disease, with no abdominal pain and at least one or more colonic diverticulum identified
on endoscopy, barium enema or CT scan
Irritable bowel syndrome, which has been diagnosed by a gastroenterologist at the hospital using ROME II or III
criteria
Age 18–85 years
Handedness Right
Informed consent Yes
Exclusion criteria
General: Pregnant or lactating women
Severe co-morbidity; for example, heart failure, respiratory failure, alcoholism, or drug dependence
Participation in any other study on Nottingham University campus in the last 3 months
No restrictions on the use of HRT, contraceptives medications, or timing of menstrual cycle with the study day
were imposed
Metallic implants
or objects
Cardiac pacemaker
Implanted cardiac defibrillator
Metallic heart valves
Aneurysm clips
Carotid artery vascular clamp
Neurostimulator
Insulin or infusion pump or implanted drug infusion device
Non-removable cochlear, otologic, or ear implant
Shot or shrapnel inside the body
Metallic fragments in the eye
Medications Inability to stop NSAIDs (non-steroidal anti-inflammatory agents), antibiotics or immunosuppressant drugs or taking
antiepileptic, gabapentin, long-term opiates, or antipsychotic medications 28
Participants taking ondansetron were included in the study, but the medication was not taken until after the
study 29–32
No exclusions for patients taking antihypertensive medications, diuretics, alcohol,33 or caffeine 34 prior to the study
Inflammatory conditions Presence of other gastrointestinal conditions such as ulcerative colitis, Crohn’s disease and Celiac disease,
malignancy, cirrhosis, current hematological malignancy, untreated peptic ulcer disease, Polymyalgia rheumatic
Abdominal surgery Previous abdominal surgery (other than appendectomy, hysterectomy, cholecystectomy and sterilization,
hernia repair)
Neurological conditions Previous diagnosis of neurological conditions, for example, stroke, cerebral malignancy, essential tremor,
Parkinson’s disease and Parkinson plus syndromes, motor neuron disease, dementia, storage disorders,
Wilsons disease e.t.c. Peripheral neuropathy (e.g., diabetic, alcohol, stroke)
Other Claustrophobia, broken skin
© 2016 The Authors.
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experienced’. This test was repeated with different temperature
until a VAS score of 6–7 was given. This temperature was
designated to be the MPT and used as the individualized painful
stimulus for the study.
Functional magnetic resonance imaging data were acquired on a
3 T Philips Achieva MR scanner using a 32-channel receive coil.
Participants viewed a projection screen in front of the magnet bore
using a mirror attached to the receive coil. Participants were
instructed to focus on the small blue cross projected on the screen
which changed to a white cross to give a visual anticipation ‘cue’
prior to any stimulus. Participants were asked to pay attention to
the screen and to the heat stimulus when delivered. Two pseudo-
randomized thermal stimulation paradigms shown in Fig. 1B were
delivered based on published studies.25–28 Each paradigm was of 8–
9-min duration and applied to the left hand and foot. The paradigms
included theMPT and a standardized temperature of 45 °C for each
participant. However, not all participants could tolerate this
temperature, and it was reduced by 0.5–2 °C for some participants.
Stimuli which had an anticipation cue of only 2–3 s were also
incorporated into the paradigms, to prevent participants predicting
the commencement of each stimulus. These shortened cues and
stimuli were called ‘blanks’. The order of which paradigm was
applied towhichbody sitewas randomizedprior to commencement
of the study. A 15-min breakhalfway through the studywasused to
prevent fatigue and reduced concentration. The participants then
returned to the scanner, where the study was completed.
A
B
Figure 1 (A) Study flow diagram and Basic.
(B) Paradigm design.
© 2016 The Authors.
Neurogastroenterology & Motility Published by John Wiley & Sons Ltd.
903
Volume 28, Number 6, June 2016 Anticipation of thermal pain in DD
fMRI data acquisition
The image acquisition used for the fMRI study was a single-shot,
double-echo, gradient echo echo-planar imaging (EPI), with echo
times (TE) of 25/50 ms, a 80 9 77 matrix of 40 contiguous 3-mm
isotropic slices covering the whole brain. One hundred and
seventy-seven dynamic scans were acquired during a single
thermal stimulation paradigm in which thermal stimulation was
applied to the foot or the hand. Axial images were aligned along the
AC–PC axis to aid the minimization of susceptibility artifacts in
the orbito-frontal cortex arising from the nasal cavity. Other scan
parameters were SPIR fat suppression and a 80° flip angle to match
the Ernst angle for the repetition time (TR) of 3s. A T1-weighted
MPRAGE anatomical image (256 9 256 matrix, 160 slices, 1-mm
isotropic resolution, TE/TR = 3.8/8.2 ms, 8° flip angle, 5 min
acquisition time) was collected at the end of the fMRI session.
Psychometric data analysis
A PHQ-12 SS score of ≤6 (Low somatization score SDD; LSDD)
or ≥7 (High somatization score SDD; HSDD) was used to
separate the SDD patients into two groups based on our previous
work.18 Participant questionnaire data were analyzed in SPSS
(version 15; IBM, Portsmouth UK) and GraphPad Prism (Version
5; San Diego, CA, USA). A Shapiro–Wilks test was performed on
the questionnaire data to test for normality. Age, bowel
frequency and HAD scores of depression and anxiety were non-
parametric, the remaining numerical data were normally dis-
tributed. Group data were compared using a Fisher-exact test,
paired t-test or Mann–Whitney U depending on the result of the
Shapiro–Wilks test, with differences being considered significant
at a p-value of <0.05.
fMRI data analysis
All fMRI images were analyzed using SPM8 (http://www.-
fil.ion.ucl.ac.uk/spm). Images were corrected for movement,
slice timing, and normalized to the MNI template, following
by spatial smoothing (8-mm kernel). A general linear model
(GLM) was used to model the heat stimuli and cue period, with
each being convolved with canonical hemodynamic response
function. For each participant, motion parameters during each
paradigm were used as covariates of no interest. Blank stimuli
were not modeled within the analysis (See Fig. 1B). First-level
fixed effects analysis was performed for each participant. Antic-
ipation data from ‘blank’ stimuli were not analyzed. Data
included in the second-level analysis was based on completed
questionnaire data being obtained, satisfactory data collection for
all of the paradigms and anatomic sites. This resulted in 14
participants per analysis group. Second-level random effects
(RFX) group analysis for the anticipation cue stimulus (uncor-
rected p < 0.001, voxel threshold 5) was performed. In addition, a
two-sample t-test was performed to compare the response to
‘cue’ events between each group (IBS, ADD and SDD) at an
uncorrected p < 0.05, and cluster threshold of 5. All active
clusters were identified using the WFU Pick Atlas (version 2.4).42
Covariates of interest such as anxiety and depression scores on
the HAD questionnaire, total PCS, and PHQ-12 SS were also
included in the GLM and significant brain activity which
correlated with these measures was assessed.
Figure 2 Diagram to illustrate participant
recruitment. Three participants withdrew
from the study: two after the sensory testing
and before scanning and one at the break
after the first scanning session.
© 2016 The Authors.
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RESULTS
Demographics
Four hundred and twenty-six potential participants
were sent standardized information, with 74 partic-
ipants being recruited; 18 with IBS, 20 with ADD,
and 36 with SDD, 3 participants withdrew from the
study (two from the ADD and one from the LSDD
group) (Fig. 2). Key demographic details for the
second-level RFX analysis subset, are shown in
Table 2. Significant differences in age were found
between these groups with the LSDD and ADD
groups compared to the HSDD and IBS groups, who
were younger.
Questionnaires results
Participant gastrointestinal symptoms and psycholog-
ical questionnaire results Demographics and gastroin-
testinal pain symptoms in each group are shown in
Table 2. The LSDD, HSDD, and IBS groups PHQ-12 SS
scores were significantly higher (paired t-test) than the
ADD group, but the HSDD and IBS were not signifi-
cantly different. Paired t-test of BMI demonstrated a
significant difference between the LSDD and IBS
groups (p = 0.02), but no differences were found
between the other groups. The HSDD group had
significant higher PCS and HAD scores compared to
the ADD and LSDD groups, but not the IBS group. This
suggests a similarity between the IBS and HSDD
groups in terms of somatization.
fMRI results
Anticipation and pain effects Second-level analysis
demonstrated robust increases and decreases in cortical
responses to the anticipation of subsequent painful
heat at the MPT stimulus for each group (Fig. 3).
Global anticipation effects in the cue period to both
left hand and foot stimulation (uncorrected p < 0.001,
cluster threshold 5) revealed deactivation of the right
posterior insula (pINS) and the PFC in the ADD and
LSDD groups, areas which are responsible for
somatosensory pain-processing pathway and DNIC
areas, respectively (Fig. 3). For all groups, increased
activation was observed in affective pain regions,
including the anterior insula (aINS) and left ACC in
both SDD and IBS groups.
Inter-group differences in cortical response to
anticipation
Inter-group analysis of the cortical regions associated
with anticipation was performed to assess differences
between the groups in key pain-processing regions
(uncorrected p < 0.05 voxel threshold 5) (Figs 4 and 5,
Table S1).
Somatosensory pain-processing regions (pINS, THAL)
Greater deactivation was found in the right pINS in the
ADD compared to the LSDD (Fig. 4A) and IBS groups
(Fig. 5A), and in the bilateral pINS in the ADD
compared to the HSDD group (Fig. 4B). Greater right
pINS deactivation was also seen in the LSDD
Table 2 Analysis of group demographics and questionnaire data
fMRI analysis groups (n = 14) ADD LSDD HSDD IBS
Female 6 (42.9%) 8 (57.1%) 11 (78.8%) 11 (78.8%)
Age (years), median (IQR) 61.5 (60–66.5) 62 (57.75–66.5) 54.5*,+ (51–58.75) 46.5**,+ (41.25–47.75)
Previous diverticulitis 0 50% 35.7% 0
Past psychiatric history 28.6% 7.1% 21.4% 42.9%
BMI (kg/m2), median (IQR) 26.5 (23.4–28.1) 28.0 (25.3–31.6) 30.5 (24.2–31.4) 24.4+ (23.5–27.8)
Gastrointestinal symptoms
Days/month of pain (<24 h), median (IQR) 0 3* (0–11) 15*** (5–28) 7.5*** (3.3–12)
Pain duration (h), median (IQR) 0 1.5* (0–5) 6** (3.4–2.4) 2.5** (0.8–12)
Sensory testing
Median VAS temperature HAND (°C) (range) 45.4 (39.5–49) 43.8 (41.5–47.5) 43.8 (41–48) 43.8 (40–49)
Median VAS temperature FOOT (°C) (range) 45.5 (40–48) 43.5 (42–49.5) 43.8 (40.5–47.5) 44.5 (41.5–48.5)
Questionnaire data
PHQ-12 SS, median (IQR) 2.5 (2–3) 4* (4–5) 8***,+++ (8–9) 8*,+ (5–8.75)
HAD: anxiety, median (IQR) 5.5 (3.75–7) 5.5 (3.25–7) 8.5*,+ (6.25–11.75) 7 (3–10)
HAD: depression, median (IQR) 2.5 (1–3) 2 (1.25–3.75) 6.5*,+ (4–8.75) 4.5 (2–5.75)
Pain catastrophizing score, median (IQR) 11 (2.5–14.5) 3.5 (1.25–15.5) 14.5+ (10.5–17.75) 11 (7.75–17.75)
ADD vs group *p < 0.05, **p < 0.001, ***p < 0.0001. LSDD vs group +p < 0.05, ++p < 0.001, +++p < 0.0001. ADD, Asymptomatic diverticular disease;
LSDD, Low somatization score diverticular disease; HSDD, High somatization score diverticular disease; IBS, Irritable bowel syndrome; IQR,
Interquartile range.
© 2016 The Authors.
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compared to the IBS group (Fig. 5B) but the difference
between the LSDD and HSDD groups was not signif-
icant. Interestingly, the HSDD group showed less
bilateral pINS deactivation compared to the IBS group.
The HSDD group also demonstrated less deactivation
in the left ventral posterolateral nucleus of the thala-
mus compared to the ADD. In the LSDD group, greater
deactivations were found in the left ventral lateral
nucleus of the thalamus and pulvinar compared to the
IBS group (Fig. 5B). No difference in thalamic activity
was identified between the SDD groups.
Emotional pain processing regions (aINS, mINS, ACC,
MCC, AMYG, parahippocampus) Greater positive
activation was identified in several emotional pain
processing areas in the SDD and IBS groups compared
to the ADD group. Greater activation in the bilateral
aINS/mINS in the LSDD and left aINS in the IBS and
HSDD groups was seen compared to the ADD group
(Fig. 4C), and greater aINS/mINS activation in the
LSDD compared to IBS and HSDD groups. Between all
the groups, different areas of the mid-cingulate showed
activation. Notable differences were identified in the
left ACC in the LSDD group compared to the HSDD
group (Fig. 5C).
Greater deactivation was seen in the AMYG in the
ADD compared to the HSDD group (Fig. 4B) and the
hippocampus in the ADD compared to the HSDD and
IBS groups (Fig. 5A). Interestingly no difference was
detected in these regions between the ADD and LSDD
groups (Fig. 4A). However, greater left AMYG and right
hippocampus deactivation was seen in the LSDD
compared to the HSDD group (Fig. 5C). Hippocampal
and parahippocampus deactivation was greater in the
ADD and LSDD groups than the IBS group (Fig. 5A).
Greater hippocampal deactivation was found in the IBS
compared to the HSDD group.
DNIC regions (PFC) Greater deactivation was seen in
the superior and superior medial frontal and parts of
the medial frontal gyrus and orbito-PFC in the ADD
compared to the IBS, LSDD, and HSDD groups
(Figs 4 and 5A). Small areas of mid frontal gyrus
activation were seen in the ADD compared to the
HSDD group and in the LSDD group compared to the
IBS and HSDD groups. In comparison greater activa-
tion of the superior frontal and inferior orbito or
operculo frontal cortex were seen in the IBS and
HSDD groups compared to the ADD groups (see
Tables S1 and S2).
Covariates analysis of cue stimulus
Increasing PHQ-12 SS scores were found to correlate
with greater deactivation of the parahippocampus and
greater positive activation in the mPFC and MCC and
Figure 3 Global BOLD effects for
anticipation of a painful stimulus applied to
the left hand or left foot for the ADD, LSDD,
HSDD and IBS groups. Negative BOLD
effects are depicted in the blue color
spectrum while positive BOLD effects are
show in the red–yellow spectrum.
© 2016 The Authors.
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right AMYG/hippocampus (Table S2). In contrast,
decreasing PHQ-12 SS scores correlated with greater
deactivation of the AMYG, hippocampus, pINS, and
the lateral and orbito-PFC.
The anxiety component of the HAD score positively
correlated with the activation of emotional processing
regions, including greater left aINS and right AMYG
activity, while decreasing anxiety scores correlated
with deactivation of the right AMYG and left hip-
pocampus. In comparison, the depression component
of the HAD score positively correlated with greater
activation of the left hippocampus, ACC and PCC,
while decreasing depression score correlated with
greater activation of the MCC and greater deactivation
of the ACC, right AMYG, parahippocampus and left
hippocampus. Similar findings were identified for the
increasing PCS scores which correlated with parahip-
pocampus deactivation, while decreasing PCS scores
correlated with left aINS, ACC and PFC activation, and
hippocampal deactivation.
DISCUSSION
This study has demonstrated changes during anticipa-
tion in the somatosensory and emotional pain-proces-
sing regions and DNIC regions, which alter across
ADD, LSDD, HSDD, and IBS groups. Greater deacti-
vations were seen in the pINS in the ADD compared to
the LSDD, HSDD, and IBS groups (Fig 4). The pINS is
key in discriminative-sensory pain processing.43 Deac-
tivation of the pINS during anticipation has been
identified in healthy volunteers compared to IBS
patients,21 which supports our findings that greater
deactivations are characteristic of the group with lesser
symptoms. Greater pINS deactivation is correlated
with decreasing PHQ-12 SS score but it did not
correlate with scores of catastrophizing, anxiety, or
depression. Similar findings have been reported in
other studies of somatization, although in this study,
significant correlations with somatization score was
not confirmed.44 A reduction in pINS, and in aINS,
THAL, and hippocampal responses, in IBS patients has
been identified after hypnotherapy compared to educa-
tional interventions,45 which may be related to better
coping methods in treated individuals, and may
explain the link with somatization.
Greater deactivation of the thalamus was found in
the ADD and IBS groups compared to HSDD group, and
in the LSDD group compared to IBS group. The
thalamus is also a key area in the somatosensory
pain-processing pathway, forming part of the spinotha-
lamic tracts with fibers running to the pINS46 and
motor responses to pain. In our study the ventral
posterolateral thalamic nucleus, which receives signals
from the spinothalamic tracts and projects to the
primary somatosensory cortex,47 was demonstrated to
A
B
C
Figure 4 Areas which have statistically more significant deactivation
in the ADD group than (A) the LSDD group and (B) the HSDD group.
(C) shows areas for which positive activations in the LSDD and HSDD
groups is statistically more significant than the ADD group.
Deactivations are depicted in the blue color spectrum while
activations are show in the red–yellow spectrum.
© 2016 The Authors.
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deactivate in the ADD compared to the HSDD group.
This observation agrees with healthy volunteer studies
of placebo analgesia in rectal pain, where responders to
placebo analgesia were noted to have a reduction in
thalamic response48 and animal models.49 In the LSDD
group, deactivation of the ventral lateral nucleus and
pulvinar were observed compared to the IBS group. The
ventral lateral nucleus outputs projections to the
motor cortex, and may be involved in motor responses
to pain. The pulvinar has connections to the ACC,
prefrontal cortex, and AMYG,50–52 which has been
shown have heightened connectivity with the pINS
during pain anticipation in patients with major depres-
sive disorder (MDD).53 Similarly positive correlation
between scores for neuroticism and thalamus activity
during pain anticipation in healthy volunteers has also
been identified.54 Deactivation in the pINS, pulvinar,
and posterolateral thalamus is suggestive of prepara-
tion for anticipated pain in our ADD and LSDD groups,
which is reduced or absent in our chronic pain groups.
The affective processing regions demonstrated
greater activation during anticipation in our IBS and
SDD groups compared to the ADD group (Fig. 4). The
aINS is a key area in affective pain processing and is
important for interoception,55 emotional awareness,55
and risk prediction.56 Greater activation of the aINS
during anticipation has also been found in healthy
volunteers57 and other pain groups, such as anorexia
nervosa and IBS.58,59 Anxiety can influence INS activ-
ity during anticipation60,61 as was also demonstrated in
our study (Table S2). This suggests a greater emotional
response to impending pain processing in our SDD and
IBS groups.
There was a lack of deactivation in the MCC and
ACC in our chronic pain groups (HSDD and IBS)
compared to the ADD group (Fig. 4). The ACC and/or
MCC have previously been identified in studies of
healthy volunteers25,57 and IBS pain anticipation21,62
and it is thought that cingulate cortex activation may
be related to attention,63 affective processing of painful
stimuli, reward probability and risk,64 and information
flow between somatic and emotional brain regions.65,66
A reduction in ACC and MCC activation during
anticipation of pain has also been identified in IBS
patients during placebo67 and longitudinal studies with
repeated stimulations.62 Anxiety also influences MCC
A
B
C
D
Figure 5 Inter-Group Analysis: Areas which have statistically more
significant deactivation or activation during the cue stimulus in the
(A) LSDD than the HSDD group, (B) the LSDD than the IBS group, (C)
the ADD than the IBS group, and (D) the IBS compared to the HSDD
group. Deactivations are depicted in the blue color spectrum while
activations are show in the red–yellow spectrum.
© 2016 The Authors.
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activation during ‘cued’ sham gastric distensions.68
This may be why deactivation in the MCC was
negatively correlated with HAD anxiety score in our
study. The ACC may also be important before the
anticipation phase, as resting-state functional connec-
tivity between the ACC and medial PFC has been
correlated with changes in ‘cued’ pain score.69 Thus,
greater ACC activation and a failure to deactivate the
MCC during anticipation may suggest alteration in
connectivity between the somatic and emotional brain
regions in our chronic pain groups.
Differences were identified in other affective areas,
with greater deactivations in AMYG and hippocampal
areas in the ADD group compared to the LSDD, HSDD,
and IBS groups (Fig 4). These areas have been reported
by other groups in healthy volunteers during pain
anticipation.21,70 In our study IBS showed less deacti-
vation in the AMYG and hippocampus than LSDD
and ADD groups. Several studies in IBS have reported
greater AMYG or hippocampal activation during antic-
ipation59,71 which decreases with increased study
familiarity62 (longitudinal studies) and reduced anxi-
ety. Deactivations of the AMYG and hippocampus
were related to both PHQ-12 SS, anxiety, depression,
and PCS scores. Higher PHQ-12 SS scores were asso-
ciated with less deactivation of the right amygdala and
bilateral hippocampus regions, suggesting that these
areas play an important role in controlling pain
sensation. The PHQ-12 SS and PCS scores also posi-
tively correlated with the deactivation of the bilateral
parahippocampus and positive activation of the right
AMYG/hippocampus. Anxiety score was positively
correlated with greater left amygdala activity, and both
depression and anxiety score were negatively corre-
lated with right AMYG and left hippocampal deacti-
vation. These findings agree with anticipation studies
in MDD patients, where AMYG activity was corre-
lated with perceived helplessness scores.72 Minimal
differences in hippocampal activity between high- and
low-anxiety states have been identified in people with
chronic daily symptoms.43 Thus, greater deactivation
in the AMYG and hippocampus may represent reduced
anxiety and somatization in the ADD and LSDD in the
face of expected pain, that is, better coping, compared
to the IBS and HSDD groups. This may underlie some
of the differences in anticipatory brain responses71 and
underlying pathophysiology and treatment strategies
for our LSSD and HSDD groups, and gives light on the
differences in underlying pathophysiology and possible
treatment strategies.
Descending noxious inhibitory control regions
showed important differences across patient groups.
The DNIC contains many regions including the
hypothalamus, AMYG, ACC, periaqueductal gray,
and DLPFC.73 The role of the frontal cortex in the
DNIC is complex and not well understood. The DLPFC
is a functional area mainly found in the medial frontal
gyrus (mPFC), but can include parts of the superior
frontal gyrus (Brodmann’s areas 8, 9, 10, and 46).74 The
mPFC/DLPFC is thought to aid control over atten-
tional, emotional, and descending inhibitory or facility
processes in pain.75 The mPFC and ACC also interact
with the AMYG, PAG, and nucleus accumbens.76 In
our study, greater superior, superior medial, and mPFC
(which includes the DLPFC), orbito-FC, and AMYG
deactivation was seen in the ADD and the LSDD group
compared to the HSDD and IBS groups. This agrees
with a meta-analysis of pain anticipation, where
deactivations of the superior frontal gyrus were iden-
tified.77 In comparison, greater superior frontal gyrus,
inferior orbitoFC, and MCC activation was identified
in the HSDD and IBS groups compared to the ADD.
This again agrees with other studies where activation
in the DLPFC was identified during pain anticipation
in patients with fybromyalgia, MDD, and recovering
anorexics.58,78 Descending noxious inhibitory control
regions have been observed to be absent in IBS groups
compared to healthy controls,21 which may contribute
to visceral hypersensitivity in these patients. Regions
of the Superior, superior medial, and/or medial frontal
gyrus deactivations were also correlated with decreas-
ing PHQ-12 SS, PCS, and depression scores in our
study, which has also been demonstrated in healthy
volunteer studies of self-reported anxiety.75 This
change in the PFC activity may be important in future
studies assessing the effect of medications in SDD, as
anticipatory PFC activity can predict greater symptom
improvement after 5HT3R antagonist Alosetron in IBS
patients.78,79
Limitations
Firstly, the participants for this study were recruited
through clinics and advertisements and no attempt
was made to age or sex match the groups resulting in
groups with characteristic ages and sex for each
medical condition. No attempt was made to control
for stage of menstrual cycle,80,81 oral contraceptive,
testosterone levels,82–84 or hormone replacement ther-
apy use,85,86 for the duration of chronic pain symptoms
or for periods of pain exacerbation or remission due to
practical considerations. Although this increases the
generalizability of our results as it more accurately
reflects the patient population, we also acknowledge
that there are known differences in fMRI pain process-
ing between genders,87,88 age89–91 groups, and hor-
© 2016 The Authors.
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monal mechanisms,82–86 which may have influences
our results. However, we did control for factors, such
as increased risk of cardiovascular disease, which may
alter blood flow dynamics and cause confounding and
we also excluded patients on medications which are
thought to the effect of blood flow dynamics such as
antiepileptic, antipsychotic, and anxiolytic medica-
tions, such as gabapentin.28,92,93 Even with these
measures, the age difference between the groups maybe
important as age-related changes in brain volume in
areas involved in pain processing31,89 and DNIC
responses31 have been identified. Similar changes to
brain volume and pain processing have also been
associated with pain duration, which may also have
affected our results.94–96 Visceral and cutaneous hyper-
sensitivity is known only to affect a subset of patients
with IBS.97 In our study, we did not investigate or
select our patients based on this phenomenon. This
again may have influenced our results as we may not
have had sufficient power to detect altered cutaneous
sensitivity between our groups.
Clinical implications
This study has demonstrated differences in anticipated
pain processing between diverticular patients with low
and high somatization score which has implications for
clinical management. There were similar cortical pat-
terns of activity between the HSDD and IBS in whom
central abnormalities of pain processing predominate.
Our results are compatible with our hypothesis that
LSDD results from a predominantly peripheral patho-
physiological pain process, while HSDD is predomi-
nantly central.22 Several studies in healthy volunteers
and/or patients with central changes in pain processing,
such as IBS, have shown responses to centrally acting
medications or techniques such as hypnotherapy or
meditation techniques.97,98 These may be useful treat-
ments which should be evaluated in patients with SDD
with high somatization scores. The PHQ-12 SS scale is
a simple 12-item scale which could be readily admin-
istered in the clinic to identify such patients who may
have suboptimal outcomes with surgical intervention
but might respond to psychological therapies or
medical treatments.
CONCLUSIONS
This is the first study to identify differences in
anticipatory pain processing between ADD and SDD.
Our study suggests that by classifying SDD patients
into high- and low-somatization groups, it is possible
to identify altered anticipatory responses to thermal
pain. This suggests underlying differences in pain
pathophysiology in these groups, and that SDD
patients need individualized treatment strategies to
target the causes of their chronic pain.
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